PD 158780
≥97%
- Product Code: 99149
CAS:
171179-06-9
| Molecular Weight: | 330.19 g./mol | Molecular Formula: | C₁₄H₁₂BrN₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00942160 | |
| Melting Point: | 174-178°C | Boiling Point: | 499.6°C at 760 mmHg |
| Density: | 1.611±0.06 g/cm3 (20 ºC 760 Torr) | Storage Condition: | -20°C |
Product Description:
PD 158780 is primarily used in research settings as a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is employed to study the role of EGFR signaling in various cellular processes, including cell proliferation, differentiation, and survival. Researchers utilize it to investigate the mechanisms of cancer development and progression, as EGFR is often overactive in many types of tumors. Additionally, PD 158780 is used to explore potential therapeutic strategies targeting EGFR in cancer treatment. Its ability to inhibit EGFR activity makes it a valuable tool in preclinical studies aimed at understanding and developing targeted therapies for EGFR-driven cancers.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Very pale yellow - Yellow Crystal - Powder |
| PURITY | 96.5-100 |
| MELTING POINT | 174.0-178.0 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿11,880.00 |
+
-
|
PD 158780
PD 158780 is primarily used in research settings as a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is employed to study the role of EGFR signaling in various cellular processes, including cell proliferation, differentiation, and survival. Researchers utilize it to investigate the mechanisms of cancer development and progression, as EGFR is often overactive in many types of tumors. Additionally, PD 158780 is used to explore potential therapeutic strategies targeting EGFR in cancer treatment. Its ability to inhibit EGFR activity makes it a valuable tool in preclinical studies aimed at understanding and developing targeted therapies for EGFR-driven cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :